| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.0039 | 1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |